L'ARC soutient les recherches menées à l'IRCL - IRCL
Actus Congrès - Chicago 2022 - j3 - Tribune'K Hemato
Michaela REAGAN | Professor (Associate) | BS, PhD | Research profile
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
Salomon Manier
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
IACH Journal Club – International Academy for Clinical Hematology (IACH)
ide-cel and neurotoxicity | Int'l Myeloma Foundation
Massimo Corsaro (@Massimo_Pfizer) / Twitter
Antibody-drug Conjugates in Relapsed/Refractory Multiple Myeloma: from Bench to Bedside - Springer Healthcare IME
Pr Salomon MANIER - Auteur | Edimark
☎️ Contacts du Dr Salomon Manier, Hematologue à Lille 59000
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
Faculty – The 9th COMy World Congress
ide-cel and neurotoxicity | Int'l Myeloma Foundation
2022 - Les débats des CTI 360° - JO - Revue Immunité & Cancer
L'ARC soutient les recherches menées à l'IRCL - IRCL
Dr. Karma Salem, MD – Atlanta, GA | Radiology
ASH 2022: Multiple Myeloma Highlights - The ASCO Post
Salomon Manier's research works | Centre Hospitalier Universitaire de Nancy, Laxou (CHU Nancy) and other places
GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
Pr Salomon MANIER - Auteur | Edimark
ide-cel and neurotoxicity | Int'l Myeloma Foundation
IACH on Twitter: "Join us TODAY at 2pm Eastern Time (Atlanta), 8pm CET (Paris) for live news from #ASH21 with Dr. Salomon Manier and @Mohty_EBMT Register Free here: https://t.co/bdQmP2b0TS https://t.co/oYQD70BBZf" / Twitter
Daniel Auclair on Twitter: "Great panel on #myeloma precursor conditions @AACR #AACRMDT21 meeting with @IreneGhobrial @DrOlaLandgren @mvmateos @JHillengass and Salomon Manier #mmsm https://t.co/dls0ZEaoFE" / Twitter
L'ARC soutient les recherches menées à l'IRCL - IRCL
Therapy of relapsed-refractory multiple myeloma - Springer Healthcare IME
